Proteins at the Plasma Membrane: What Protein Domains Are on the Outside and What Domains Are on the Inside?

Total Page:16

File Type:pdf, Size:1020Kb

Proteins at the Plasma Membrane: What Protein Domains Are on the Outside and What Domains Are on the Inside? Proteins at the plasma membrane: What protein domains are on the outside and what domains are on the inside? Kanthida Kusonmano Kwanjeera Wanichthanarak Natapol Pornputtapong Chalmers University of Technology, Sweden The cover image is adopted from http://4e.plantphys.net/image.php?id=80. 1 Introduction Membrane proteins are involved in a wide range of important biological processes, such as cell signaling, transport of membrane-impermeable molecules, cell adhesion and cell–cell communication, many of which are involved in disease mechanism and drug target discovery. Thus, an understanding of their structure and function is of great importance for biological and pharmacological research. Because of the experimental difficulties, i.e. not easy to crystallize, these membrane proteins are rarely found in structural databases. Sequence-based analysis is therefore an important approach for investigating such proteins [1]. Transmembrane proteins are a class of integral proteins which penetrate into or through the lipid bilayer of cell membrane or plasma membrane. There are three regions that can be defined: the region outside the membrane, the region inside the membrane and the region in the bilayer (Figure 1). Figure 1 Representation of a transmembrane (integral membrane) protein (figure adopted from [2]) Prediction of transmembrane helices from sequence is a key challenge for bioinformatics. In this study we used TMHMM, a hidden Markov model for predicting transmembrane helices in protein sequences [3], to predict the location and in/out orientation of human transmembrane helices. Then, we investigated further for the protein domains of in/out transmembrane regions using HMMER, a tool for searching protein homologs and for making sequence alignments [4]. The tool was implemented based on profile hidden Markov models (profileHMMs). 2 Material and methods To examine human transmembrane proteins, we first retrieved all human proteins from UniProt/SwissProt [5]. Since there are both plasma membrane and internal membranes e.g. ER membrane in a human cell, in order to identify only the proteins of the plasma membrane or transmembrane proteins, we used two Gene Ontology (GO ) terms; ‘plasma membrane’ and ‘integral to membrane’. After getting the set of transmembrane proteins, we performed two tasks in parallel: 1. Predict transmembrane helices TMHMM was used to predict the location and in/out orientation of transmembrane helices [3]. Given a HMM, the tool predicts transmembrane helices by finding the most probable topology of a given residue. There are three possibilities whether a given residue is on the cytoplasmic side (intracellular), on the periplasmic side (extracellular), or in a transmembrane helix (within membrane). 2. Identify domains of transmembrane proteins HMMER was used to identify the protein domains of transmembrane proteins [4 ]. The tool is based on profileHMMs and it is used for searching functional domains on given protein sequences. Pfam-A profiles, which are derived from high quality and manually curated protein domains in Pfam database [6], were used as query profiles. Prediction is performed by hmmsearch program which is a part of HMMER package with cut-off score at 10E-5. Information from both TMHMM and HMMER were combined to distinguish domains of in/out transmembrane regions. Analytical steps for transmembrane proteins are illustrated in Figure 2. 3 Figure 2 Analytical pipeline of human transmembrane proteins 4 Results and discussions Transmembrane prediction As mention earlier, the structure of transmembrane proteins can be defined into three parts; intracellular, extracellular and transmembrane helix. All of transmembrane proteins have the same core structure which is the transmembrane helix mostly having specific functions of membrane integration and transportation. There are 1076 transmembrane proteins which were collected from UniProt/SwissProt database based on “Plasma membrane” and “Integral to membrane” keywords of Gene Ontology definition. A Ruby script was used to parse data from UniProt/EBI format into fasta format as shown in appendix A. Figure 3 Number of transmembrane helix of human transmembrane proteins TMHMM was used to predict the location and in/out orientation of transmembrane helices for these transmembrane proteins. The number of predicted transmembrane helix from TMHMM are varied from no transmembrane helix to 14 transmembrane helices as shown in Figure 3. 43 transmembrane proteins were unable to identify transmembrane helix which is probably because of limit capability of TMHMM 5 algorithm. After tracing back to UniProt, most of transmembrane types for such group are signal-anchor helix which may have different properties from general transmembrane helix. Thus these proteins will not be included in domain prediction step. Among the rest of transmembrane proteins, the most common number of transmembrane helix is 7. This group of transmembrane proteins relates to the G protein-coupled receptors (GPCRs), the largest group of transmembrane proteins. Even though these transmembrane proteins share core functional unit, i.e. 7- transmembrane helix, many of them contain different functional domains in extra and intracellular region [7]. Domain prediction In addition to transmembrane helix, the other parts are extracellular and intracellular regions which do not insert into the membrane. Diverse functions of membrane proteins are based on functional domains that present in these two regions. There are 237 domains assigned to 2316 positions of the proteins. HMMER provides the positions of predicted-functional domains while TMHMM results give the in/out orientation of transmembrane helices. Combining results from HMMER and TMHMM, we can categorize predicted domains into three groups: domains on transmembrane helix, domains in intracellular and domains in extracellular. 1. Domains on transmembrane helix This group of domains is situating on most parts of transmembrane region, in other words they cover many topological domains or almost whole part of transmembrane proteins. The properties of domains found in this region is very similar. It shows the properties of membrane integration which only confirm the prediction from TMHMM. There are 97 domains (shown in appendix B) in this group and most of them belong to 7-transmembrane GPCRs family. Nearly half of proteins that we used in this prediction have GPCRs domain family on their sequence. This correlates to the results from TMHMM part. 2. Domains in intracellular region Domains in this group were predicted to be in intracellular position by TMHMM. Intracellular domain is a part of transmembrane protein that contact to cytoplasm. There are only 16 domains assigned into this group. It is very small when compare to the others. Functions of these domains suppose to be the domains that connect to intracellular components such as, cell structure, metabolism and signal transduction activities. In this study, we found many of them are functioning as binding regions. Functions of intracellular domains are not much diverse when compare to domains of extracellular region. The most 6 common domain is cadherin_C or Cadherin cytoplasmic region, a part of protein commonly found on cadherin protein. Cadherin protein is a member of cell adhesion molecules which are needed during tissue differentiation. The cadherin cytoplasmic region is cytoplasmic tails which link the cytoskeleton by catenins. The other domains are shown in appendix C. 3. Domains in extracellular region This is the largest group of domains that we classified in this study. There are 110 domains found in extracellular regions of transmembrane proteins. From description data of Pfam database, most of them are non-specific to extracellular regions. In other words, we cannot be certain which domains are specific to the inside or outside of the cell. Only 14 domains are highly specific to extracellular regions as shown in appendix D, for example Cadherin, ig, SEA and Sushi. In addition, we found that a domain, classified from Pfam as an intracellular domain, was found in this prediction as an extracellular domain. This domain is the calx-beta. The calx-beta domain is a tandem repeat in the cytoplasmic domains of Calx Na-Ca exchanger, also presents in the cytoplasmic tail of mammalian integrin-beta4. This motif is used for calcium binding and regulation [8]. There are 3 proteins which were predicted to contain Calx beta domain. To prove the correctness of prediction, we plotted domain architecture of two proteins which have Calx beta domain as show in figure 4 and 5. Predicted Calx beta domain usually comes along with other extracellular domains like VWC, EPTP and GPS. This conflict may be from TMHMM or this domain has another function in extracellular region. Some domains are detected in both intracellular and extracellular regions based on TMHMM. These might be because of either wrong predictions of positions and orientations from TMHMM or false positive from HMMER. Table in appendix E shows predicted domains occurred in intracellular and extracellular group. There are some domains such as I-set, and V-set which highly dominate in extracellular than intracellular. 7 Figure 4 Transmembrane helices and functional domains position of protein Q8WXG9 Figure 5 Transmembrane helices and functional domains position of protein Q86XX4 8 References 1. Nugent T and Jones DT, 2009, Transmembrane protein topology prediction using support vector machines, BMC Bioinformatics, 10:159. 2. Hurwitz N, Pellegrini-Calace
Recommended publications
  • Searching for Novel Peptide Hormones in the Human Genome Olivier Mirabeau
    Searching for novel peptide hormones in the human genome Olivier Mirabeau To cite this version: Olivier Mirabeau. Searching for novel peptide hormones in the human genome. Life Sciences [q-bio]. Université Montpellier II - Sciences et Techniques du Languedoc, 2008. English. tel-00340710 HAL Id: tel-00340710 https://tel.archives-ouvertes.fr/tel-00340710 Submitted on 21 Nov 2008 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE MONTPELLIER II SCIENCES ET TECHNIQUES DU LANGUEDOC THESE pour obtenir le grade de DOCTEUR DE L'UNIVERSITE MONTPELLIER II Discipline : Biologie Informatique Ecole Doctorale : Sciences chimiques et biologiques pour la santé Formation doctorale : Biologie-Santé Recherche de nouvelles hormones peptidiques codées par le génome humain par Olivier Mirabeau présentée et soutenue publiquement le 30 janvier 2008 JURY M. Hubert Vaudry Rapporteur M. Jean-Philippe Vert Rapporteur Mme Nadia Rosenthal Examinatrice M. Jean Martinez Président M. Olivier Gascuel Directeur M. Cornelius Gross Examinateur Résumé Résumé Cette thèse porte sur la découverte de gènes humains non caractérisés codant pour des précurseurs à hormones peptidiques. Les hormones peptidiques (PH) ont un rôle important dans la plupart des processus physiologiques du corps humain.
    [Show full text]
  • The EMILIN/Multimerin Family
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE REVIEW ARTICLE published: 06 Januaryprovided 2012 by Frontiers - Publisher Connector doi: 10.3389/fimmu.2011.00093 The EMILIN/multimerin family Alfonso Colombatti 1,2,3*, Paola Spessotto1, Roberto Doliana1, Maurizio Mongiat 1, Giorgio Maria Bressan4 and Gennaro Esposito2,3 1 Experimental Oncology 2, Centro di Riferimento Oncologico, Istituto di Ricerca e Cura a Carattere Scientifico, Aviano, Italy 2 Department of Biomedical Science and Technology, University of Udine, Udine, Italy 3 Microgravity, Ageing, Training, Immobility Excellence Center, University of Udine, Udine, Italy 4 Department of Histology Microbiology and Medical Biotechnologies, University of Padova, Padova, Italy Edited by: Elastin microfibrillar interface proteins (EMILINs) and Multimerins (EMILIN1, EMILIN2, Uday Kishore, Brunel University, UK Multimerin1, and Multimerin2) constitute a four member family that in addition to the Reviewed by: shared C-terminus gC1q domain typical of the gC1q/TNF superfamily members contain a Uday Kishore, Brunel University, UK Kenneth Reid, Green Templeton N-terminus unique cysteine-rich EMI domain. These glycoproteins are homotrimeric and College University of Oxford, UK assemble into high molecular weight multimers. They are predominantly expressed in *Correspondence: the extracellular matrix and contribute to several cellular functions in part associated with Alfonso Colombatti, Division of the gC1q domain and in part not yet assigned nor linked to other specific regions of the Experimental Oncology 2, Centro di sequence. Among the latter is the control of arterial blood pressure, the inhibition of Bacil- Riferimento Oncologico, Istituto di Ricerca e Cura a Carattere Scientifico, lus anthracis cell cytotoxicity, the promotion of cell death, the proangiogenic function, and 33081 Aviano, Italy.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Multimerin-2 Is a Ligand for Group 14 Family C-Type Lectins CLEC14A, CD93 and CD248 Spanning the Endothelial Pericyte Interface
    OPEN Oncogene (2017) 36, 6097–6108 www.nature.com/onc ORIGINAL ARTICLE Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface KA Khan1, AJ Naylor2, A Khan1, PJ Noy1, M Mambretti1, P Lodhia1, J Athwal1, A Korzystka1, CD Buckley2, BE Willcox3, F Mohammed3 and R Bicknell1 TheC-typelectindomaincontaininggroup14familymembers CLEC14A and CD93 are proteins expressed by endothelium and are implicated in tumour angiogenesis. CD248 (alternatively known as endosialin or tumour endothelial marker-1) is also a member of this family and is expressed by tumour-associated fibroblasts and pericytes. Multimerin-2 (MMRN2) is a unique endothelial specific extracellular matrix protein that has been implicated in angiogenesis and tumour progression. We show that the group 14 C-type lectins CLEC14A, CD93 and CD248 directly bind to MMRN2 and only thrombomodulin of the family does not. Binding to MMRN2 is dependent on a predicted long-loop region in the C-type lectin domainandisabrogatedbymutationwithinthedomain. CLEC14A and CD93 bind to the same non-glycosylated coiled-coil region of MMRN2, but the binding of CD248 occurs on a distinct non-competing region. CLEC14A and CD248 can bind MMRN2 simultaneously and this occurs at the interface between endothelium and pericytes in human pancreatic cancer. A recombinant peptide of MMRN2 spanning the CLEC14A and CD93 binding region blocks CLEC14A extracellular domain binding to the endothelial cellsurfaceaswellasincreasingadherenceofhumanumbilical vein endothelial cells to the active peptide. This MMRN2 peptide is anti-angiogenic in vitro and reduces tumour growth in mouse models. These findings identify novel protein interactions involving CLEC14A, CD93 and CD248 with MMRN2 as targetable components of vessel formation.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Regulatory Function of Whey Acidic Protein in the Proliferation of Mouse Mammary Epithelial Cells in Vivo and in Vitro
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Biology 274 (2004) 31–44 www.elsevier.com/locate/ydbio Regulatory function of whey acidic protein in the proliferation of mouse mammary epithelial cells in vivo and in vitro Naoko Nukumi, Kayoko Ikeda, Megumi Osawa, Tokuko Iwamori, Kunihiko Naito, Hideaki Tojo* Laboratory of Applied Genetics, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan Received for publication 14 October 2003, revised 30 March 2004, accepted 28 April 2004 Available online 10 August 2004 Abstract Although possible biological functions of whey acidic protein (WAP) have been suggested, few studies have focused on investigating the function of WAP. This paper describes evidence for WAP function in lobulo-alveolar development in mammary glands in vivo and in the cell cycle progression of mammary epithelial cells in vitro. Ubiquitous overexpression of WAP transgene impaired only lobulo-alveolar development in the mammary glands of transgenic female mice but not other physiological functions, indicating that the inhibitory function of WAP is specific to mammary alveolar cells. The forced expression of WAP significantly inhibited the proliferation of mouse mammary epithelial cells (HC11 cells and EpH4/K6 cells), whereas it did not affect that of NIH3T3 cells. Co-culturing of WAP-clonal cells and control cells using a transwell insert demonstrated that WAP inhibited the proliferation of HC11 cells through a paracrine action but not that of NIH3T3 cells, and that WAP was able to bind to HC11 cells but not to NIH3T3 cells.
    [Show full text]
  • Identification of the Rassf3 Gene As a Potential Tumor Suppressor
    Clemson University TigerPrints All Dissertations Dissertations 12-2006 Identification of the Rassf3 Gene as a Potential Tumor Suppressor Responsible for the Resistance to Mammary Tumor Development in MMTV/ neu Transgenic Mice Isabelle Jacquemart Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations Part of the Microbiology Commons Recommended Citation Jacquemart, Isabelle, "Identification of the Rassf3 Gene as a Potential Tumor Suppressor Responsible for the Resistance to Mammary Tumor Development in MMTV/neu Transgenic Mice" (2006). All Dissertations. 26. https://tigerprints.clemson.edu/all_dissertations/26 This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by an authorized administrator of TigerPrints. For more information, please contact [email protected]. IDENTIFICATION OF THE Rassf3 GENE AS A POTENTIAL TUMOR SUPPRESSOR RESPONSIBLE FOR THE RESISTANCE TO MAMMARY TUMOR DEVELOPMENT IN MMTV/neu TRANSGENIC MICE A Dissertation Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy Microbiology by Isabelle C. Jacquemart December 2006 Accepted by: Dr. Wen Y. Chen, Committee Chair Dr. Charles D. Rice Dr. Lyndon L. Larcom Dr. Lesly Temesvari i ABSTRACT The MMTV/neu transgenic mouse line is a well-documented animal model for studying HER2/neu-related breast cancer. It has been reported that a small percentage, approximately 20%, of the virgin female MMTV/neu mice seems resistant to the development of mammary gland adenoma, despite the overexpression of the neu oncogene. To identify the factors that are responsible for the tumor resistance in these MMTV/neu female transgenic mice, comparative genetic profiling was used to screen the alterations in gene expression in the mammary gland.
    [Show full text]
  • Characterisation of Eppin Function: Expression and Activity in the Lung
    ORIGINAL ARTICLE LUNG BIOLOGY Characterisation of eppin function: expression and activity in the lung Aaron Scott1,7, Arlene Glasgow1,7, Donna Small1, Simon Carlile1, Maelíosa McCrudden2, Denise McLean2, Ryan Brown1, Declan Doherty1, Fionnuala T. Lundy2, Umar I. Hamid2, Cecilia M. O’Kane2, Daniel F. McAuley2, Malcolm Brodlie3, Michael Tunney4, J. Stuart Elborn2, Chris R. Irwin5, David J. Timson 6, Clifford C. Taggart1 and Sinéad Weldon1 Affiliations: 1Airway Innate Immunity Research Group, Centre for Experimental Medicine, Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, UK. 2Centre for Experimental Medicine, Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, UK. 3Paediatric Respiratory Unit, Great North Children’s Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. 4Halo, School of Pharmacy, Queen’s University Belfast, Belfast, UK. 5Centre for Dentistry, Queen’s University Belfast, Belfast, UK. 6School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK. 7Joint first authors. Correspondence: Cliff Taggart, Airway Innate Immunity Research Group, Centre for Infection and Immunity, Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, BT9 7BL, UK. E-mail: [email protected] @ERSpublications Eppin is a low-molecular-weight protein which is expressed in the human lung during inflammation http://ow.ly/WZuQ30aELEI Cite this article as: Scott A, Glasgow A, Small D, et al. Characterisation of eppin function: expression and activity in the lung. Eur Respir J 2017; 50: 1601937 [https://doi.org/10.1183/13993003.01937-2016]. ABSTRACT Eppin is a serine protease inhibitor expressed in male reproductive tissues. The aim of this study was to investigate the localisation and regulation of eppin expression in myeloid and epithelial cell lines, and explore its potential role as a multifunctional host defence protein.
    [Show full text]
  • EGFL7 Meets Mirna-126: an Angiogenesis Alliance
    - http://vascularcell.com/ REVIEW | OPEN ACCESS EGFL7 meets miRNA-126: an angiogenesis alliance Journal of Angiogenesis Research 2:9 | DOI: 10.1186/2040-2384-2-9 | © Li et al.; licensee Publiverse Online S.R.L. 2010 Received: 21 Apr 2010 | Accepted: 8 Apr 2010 | Published: 8 Apr 2010 Nikolic Iva, Plate Karl-Heinz, Schmidt Mirko HH@ + Contributed equally@ Corresponding author Abstract Blood vessels form de novo through the tightly regulated programs of vasculogenesis and angiogenesis. Both processes are distinct but one of the steps they share is the formation of a central lumen, when groups of cells organized as vascular cords undergo complex changes to achieve a tube-like morphology. Recently, a protein termed epidermal growth factor-like domain 7 (EGFL7) was described as a novel endothelial cell-derived factor involved in the regulation of the spatial arrangement of cells during vascular tube assembly. With its impact on tubulogenesis and vessel shape EGFL7 joined the large family of molecules governing blood vessel formation. Only recently, the molecular mechanisms underlying EGFL7's effects have been started to be elucidated and shaping of the extracellular matrix (ECM) as well as Notch signaling might very well play a role in mediating its biological effects. Further, findings in knock-out animal models suggest miR-126, a miRNA located within the egfl7 gene, has a major role in vessel development by promoting VEGF signaling, angiogenesis and vascular integrity. This review summarizes our current knowledge on EGFL7 and miR-126 and we will discuss the implications of both bioactive molecules for the formation of blood vessels.
    [Show full text]
  • WO 2013/184908 A2 12 December 2013 (12.12.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2013/184908 A2 12 December 2013 (12.12.2013) P O P C T (51) International Patent Classification: Jr.; One Procter & Gamble Plaza, Cincinnati, Ohio 45202 G06F 19/00 (201 1.01) (US). HOWARD, Brian, Wilson; One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (US). (21) International Application Number: PCT/US20 13/044497 (74) Agents: GUFFEY, Timothy, B. et al; c/o The Procter & Gamble Company, Global Patent Services, 299 East 6th (22) Date: International Filing Street, Sycamore Building, 4th Floor, Cincinnati, Ohio 6 June 2013 (06.06.2013) 45202 (US). (25) Filing Language: English (81) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (30) Priority Data: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 61/656,218 6 June 2012 (06.06.2012) US DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (71) Applicant: THE PROCTER & GAMBLE COMPANY HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, [US/US]; One Procter & Gamble Plaza, Cincinnati, Ohio KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 45202 (US). MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, (72) Inventors: XU, Jun; One Procter & Gamble Plaza, Cincin SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, nati, Ohio 45202 (US).
    [Show full text]
  • Expression and Function of Murine WFDC2 in the Respiratory Tract
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.05.079293; this version posted May 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Bingle et al. Expression and function of murine WFDC2 in the respiratory tract. May 2020 Expression and function of murine WFDC2 in the respiratory tract. L Bingle1*, H Armes1, DJ Williams2, O Gianfrancesco2, Md M K Chowdhury2, R Drapkin3 , C D Bingle2*. 1 Academic Unit of Oral and Maxillofacial Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield, South Yorkshire, United Kingdom 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, South Yorkshire, United Kingdom. 3 Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA * Joint corresponding authors E-mail: [email protected]; [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.05.05.079293; this version posted May 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Bingle et al. Expression and function of murine WFDC2 in the respiratory tract. May 2020 Abstract. WFDC2/HE4 encodes a poorly characterised secretory protein that shares structural similarity with multifunctional host defence proteins through possession of two conserved Whey Acidic Protein/four disulphide-core (WFDC) domains.
    [Show full text]
  • The Structure, Function and Evolution of the Extracellular Matrix: a Systems-Level Analysis
    The Structure, Function and Evolution of the Extracellular Matrix: A Systems-Level Analysis by Graham L. Cromar A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Graham L. Cromar 2014 ii The Structure, Function and Evolution of the Extracellular Matrix: A Systems-Level Analysis Graham L. Cromar Doctor of Philosophy Department of Molecular Genetics University of Toronto 2014 Abstract The extracellular matrix (ECM) is a three-dimensional meshwork of proteins, proteoglycans and polysaccharides imparting structure and mechanical stability to tissues. ECM dysfunction has been implicated in a number of debilitating conditions including cancer, atherosclerosis, asthma, fibrosis and arthritis. Identifying the components that comprise the ECM and understanding how they are organised within the matrix is key to uncovering its role in health and disease. This study defines a rigorous protocol for the rapid categorization of proteins comprising a biological system. Beginning with over 2000 candidate extracellular proteins, 357 core ECM genes and 524 functionally related (non-ECM) genes are identified. A network of high quality protein-protein interactions constructed from these core genes reveals the ECM is organised into biologically relevant functional modules whose components exhibit a mosaic of expression and conservation patterns. This suggests module innovations were widespread and evolved in parallel to convey tissue specific functionality on otherwise broadly expressed modules. Phylogenetic profiles of ECM proteins highlight components restricted and/or expanded in metazoans, vertebrates and mammals, indicating taxon-specific tissue innovations. Modules enriched for medical subject headings illustrate the potential for systems based analyses to predict new functional and disease associations on the basis of network topology.
    [Show full text]